
Mustang Bio fell 70.0% from $1.18 to $0.35, behind the S&P 500's +3.2%. Its worst day was Dec 3 (−14.9%), and its low came Nov 20 at $0.35.
Nov 24, 2025 – Nov 20, 2026 · picked from earnings, analyst actions, headlines and the biggest daily moves
Mustang Bio closed at its highest level of the year, 19.5% above where the year started.
+13.7% · S&P 500 +0.5%
Mustang Bio shares fell 13.0%, while the S&P 500 fell 0.8%.
−13.0% · S&P 500 −0.8%
Story events cover the past 12 months · Times ET
EPS of $-0.07 was reported on $0.00 revenue.
−0.3% · S&P 500 −1.4%
EPS of $-0.14 was reported on $0.00 revenue.
−3.6% · S&P 500 +1.4%
Mustang Bio shares rose 14.8%, while the S&P 500 rose 0.3%.
+14.8% · S&P 500 +0.3%
Mustang Bio shares rose 12.7%, while the S&P 500 rose 0.2%.
+12.7% · S&P 500 +0.2%
EPS of $-0.16 was reported on $0.00 revenue.
−3.1% · S&P 500 −0.2%
Mustang Bio shares rose 15.1%, while the S&P 500 fell 0.4%.
+15.1%, the year's best day · S&P 500 −0.4%
Where it ended: a close of $0.35 on Nov 20, 2026. Up next: Q3 2026 earnings on Dec 4, 2026.
Nothing in the past 12 months.
All MBIO analyst actionsNothing in the past 12 months.
All MBIO dividend historyNothing in the past 12 months.
All MBIO newsChart by ChartIQ. Events, ratings, quote and fundamentals from Benzinga APIs. Daily bars for MBIO and SPY from Benzinga historical bars. Not investment advice.